| Pulmonary-to-systemic blood flow ratio effects of sevoflurane, isoflurane, halothane, and fentanyl/midazolam with 100% oxygen in children with congenital heart disease. | |
| | |
MedLine Citation:
|
PMID: 12401594 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
IMPLICATIONS: Sevoflurane, halothane, isoflurane, and fentanyl/midazolam do not change pulmonary-to-systemic blood flow ratio in children with atrial and ventricular septal defects when administered at standard anesthetic doses with 100% oxygen. |
| | |
Authors:
|
Tracy H Laird; Stephen A Stayer; Shannon M Rivenes; Mark B Lewin; E Dean McKenzie; Charles D Fraser; Dean B Andropoulos |
Related Documents
:
|
10978974 - Diagnostic catheterization and balloon sizing of atrial septal defects by echocardiogra... 9338644 - The left ventricular outflow tract in atrioventricular septal defect revisited: surgica... 12375184 - Computer-enhanced telemanipulation enables a variety of totally endoscopic cardiac proc... 17433994 - Potential implications of the helical heart in congenital heart defects. 3430644 - Lysophosphoglycerides and ventricular fibrillation early after onset of ischemia. 18823504 - C-reactive protein and coronary heart disease: a critical review. |
Publication Detail:
|
Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Anesthesia and analgesia Volume: 95 ISSN: 0003-2999 ISO Abbreviation: Anesth. Analg. Publication Date: 2002 Nov |
Date Detail:
|
Created Date: 2002-10-28 Completed Date: 2002-11-19 Revised Date: 2013-05-20 |
Medline Journal Info:
|
Nlm Unique ID: 1310650 Medline TA: Anesth Analg Country: United States |
Other Details:
|
Languages: eng Pagination: 1200-6, table of contents Citation Subset: AIM; IM |
Affiliation:
|
Division of Pediatric Cardiology, Texas Children's Hospital and Baylor College of Medicine, 6621 Fannin, Houston, TX 77030-2399, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Anesthetics, Inhalation* / administration & dosage, adverse effects Anesthetics, Intravenous* / administration & dosage, adverse effects Child Child, Preschool Double-Blind Method Echocardiography, Transesophageal Female Fentanyl* / administration & dosage, adverse effects Halothane* / administration & dosage, adverse effects Heart Defects, Congenital / physiopathology*, surgery* Heart Septal Defects, Atrial / surgery Heart Septal Defects, Ventricular / surgery Hemodynamics / drug effects* Humans Infant Isoflurane* / administration & dosage, adverse effects Male Methyl Ethers* / administration & dosage, adverse effects Midazolam* / administration & dosage, adverse effects Oxygen / administration & dosage, pharmacology* Pulmonary Circulation / drug effects* |
| Chemical | |
Reg. No./Substance:
|
0/Anesthetics, Inhalation; 0/Anesthetics, Intravenous; 0/Methyl Ethers; 151-67-7/Halothane; 26675-46-7/Isoflurane; 28523-86-6/sevoflurane; 437-38-7/Fentanyl; 59467-70-8/Midazolam; 7782-44-7/Oxygen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Aortic valve fibroelastomas as an incidental intraoperative transesophageal echocardiographic findin...
Next Document: Intrathecal versus IV fentanyl in pediatric cardiac anesthesia.